Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kobinger GP"'
Autor:
Yan J; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Morrow MP; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Chu JS; The Wistar Institute of Anatomy & Biology, 3601 Spruce St, Philadelphia, PA 19104, USA., Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Reed CC; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Khan AS; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Broderick KE; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Kim JJ; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Sardesai NY; Inovio Pharmaceuticals Inc, 660 W. Germantown Pike, Suite 110, Plymouth Meeting, PA 19462, USA., Weiner DB; The Wistar Institute of Anatomy & Biology, 3601 Spruce St, Philadelphia, PA 19104, USA. Electronic address: dweiner@wistar.org.
Publikováno v:
Vaccine [Vaccine] 2018 May 24; Vol. 36 (22), pp. 3079-3089.
Autor:
Pillet S; Medicago Inc., 1020 Route de l'Église, Bureau 600, Québec, QC, Canada; Research Institute of the McGill University Health Center, Montreal, QC, Canada., Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada., Nfon C; National Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, MB, Canada., Di Lenardo TZ; Research Institute of the McGill University Health Center, Montreal, QC, Canada., Babiuk S; National Centre for Foreign Animal Disease, Canadian Food Inspection Agency, Winnipeg, MB, Canada; Department of Immunology, University of Manitoba, MB, Canada., Ward BJ; Medicago Inc., 1020 Route de l'Église, Bureau 600, Québec, QC, Canada., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada; Department of Immunology, University of Manitoba, MB, Canada; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA., Landry N; Medicago Inc., 1020 Route de l'Église, Bureau 600, Québec, QC, Canada. Electronic address: landryn@medicago.com.
Publikováno v:
Vaccine [Vaccine] 2015 Nov 17; Vol. 33 (46), pp. 6282-9. Date of Electronic Publication: 2015 Oct 02.
Autor:
Ogunremi O; Ottawa Laboratory (Fallowfield), Canadian Food Inspection Agency, Ottawa, Ontario, Canada., Pasick J, Kobinger GP, Hannaman D, Berhane Y, Clavijo A, van Drunen Littel-van den Hurk S
Publikováno v:
Clinical and vaccine immunology : CVI [Clin Vaccine Immunol] 2013 Apr; Vol. 20 (4), pp. 491-500. Date of Electronic Publication: 2013 Jan 30.
Autor:
Laddy DJ; Special Pathogens Program, National Microbiology Laboratory, Health Canada, Canadian Science Centre for Human and Animal Health, University of Manitoba, Winnipeg, Canada., Yan J; Special Pathogens Program, National Microbiology Laboratory, Health Canada, Canadian Science Centre for Human and Animal Health, University of Manitoba, Winnipeg, Canada., Corbitt N; Special Pathogens Program, National Microbiology Laboratory, Health Canada, Canadian Science Centre for Human and Animal Health, University of Manitoba, Winnipeg, Canada., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Health Canada, Canadian Science Centre for Human and Animal Health, University of Manitoba, Winnipeg, Canada., Weiner DB; Special Pathogens Program, National Microbiology Laboratory, Health Canada, Canadian Science Centre for Human and Animal Health, University of Manitoba, Winnipeg, Canada.
Publikováno v:
Vaccine [Vaccine] 2007 Apr 20; Vol. 25 (16), pp. 2984-2989. Date of Electronic Publication: 2007 Jan 30.